logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tetsuya Mitsudomi

kindai university
H指数:113
被引数:6.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative Durvalumab for Resectable NSCLC: Updated Outcomes for Japanese Patients in AEGEAN

可切除非小细胞肺癌的围手术期Durvalumab治疗：日本患者AEGEAN研究的更新结果

Cancer Science
IF4.3
2026-09-280
OAAI
Tetsuya Mitsudomi; John V. Heymach; Yoshitsugu Horio; Fumihiro Tanaka; Hiroshi Tanaka; Shoichi Kuyama; Morihito Okada; Shinichi Toyooka; Yasutaka Watanabe; Martin Reck; David Harpole; Janis M. Taube; Yuka Olivo; Huiling Xiong; Tamer M. Fouad; Allen Chen; Hiroaki Akamatsu
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

阿特珠单抗治疗晚期NSCLC患者外周血T细胞谱及血浆蛋白质组学分析

Cancer Science
IF4.3
2026-02-020
OAAI
Atsuto Mouri; Hiroshi Kagamu; Koji Tamada; Makoto Nishio; Hiroaki Akamatsu; Yasushi Goto; Hidetoshi Hayashi; Satoru Miura; Akihiko Gemma; Ichiro Yoshino; Toshihiro Misumi; Ryota Saito; Noriko Yanagitani; Fujita Masaki; Hiroshi Nokihara; Kazumi Nishino; Masahiro Seike; Tetsunari Hase; Osamu Hataji; Hiroaki Takeoka; Yosuke Kawashima; Hirotaka Kuroki; Masamichi Sugimoto; Hiroshi Kuriki; Tetsuya Mitsudomi
Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME)

日本不可切除性III期非小细胞肺癌中 durvalumab 的长期安全性和有效性：一项多中心前瞻性研究（AYAME）

Journal of Thoracic Oncology
IF20.8
2025-08-180
OAAI
Hirotsugu Kenmotsu; Yoshinobu Saito; Kiichiro Ninomiya; Shinya Uematsu; Burak Akdemir; Ayako Fukui; Ryo Koto; Masakazu Fujiwara; Chikako Iwao; Hiroshi Kitagawa; Ichiro Yoshino; Akihiko Gemma; Tetsuya Mitsudomi; Nobuyuki Yamamoto
Clinical Utility of the 5-Point Visual Deauville Score for Preoperative Evaluation in Stage I NSCLC: A Multicenter Retrospective Study

5点视觉多维尔评分在术前评估Ⅰ期非小细胞肺癌中的临床应用价值：一项多中心回顾性研究

thoracic and cardiovascular surgery
IF0
2025-07-160
PRE
Tomoyo Fukami; Akira Hamada; Kenichi Suda; Hayato Kaida; Yukihiro Yoshida; Kazuhiro Kitajima; Kimiteru Ito; Tetsuro Sekine; Kyoshiro Takegahara; Hiromitsu Daisaki; Masaki Hashimoto; Takanobu Kabasawa; Takashi Yamasaki; Seiichi Hirota; Jitsuo Usuda; Kazunari Ishii; Junichi Soh; Tetsuya Mitsudomi; Yasuhiro Tsutani
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Xenium的单细胞空间分析揭示了放疗联合anti-PD-L1治疗后CXCL13 T和CXCL9细胞的抗肿瘤反应

British Journal of Cancer
IF6.8
2025-07-160
OA
Shunsuke A. Sakai; Hidekazu Oyoshi; Masaki Nakamura; Tetsuro Taki; Kotaro Nomura; Hidehiro Hojo; Hidenari Hirata; Atsushi Motegi; Yuka Nakamura; Junko Zenkoh; Keiju Aokage; Akira Hamada; Motohiro Kojima; Takeshi Kuwata; Katsuya Tsuchihara; Tetsuo Akimoto; Junichi Soh; Tetsuya Mitsudomi; Masahiro Tsuboi; Genichiro Ishii; Yutaka Suzuki; Ayako Suzuki; Riu Yamashita; Shun-Ichiro Kageyama
Surgical Outcomes with Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC

可切除非小细胞肺癌中，新辅助度鲁单抗联合化疗后序贯辅助度鲁单抗的手术结果

Journal of Thoracic Oncology
IF20.8
2025-06-200
PREAI
Tetsuya Mitsudomi; John V. Heymach; Martin Reck; Janis M. Taube; Shugeng Gao; Yoshitsugu Horio; Jian You; Gaofeng Li; Dinh Van Luong; Somcharoen Saeteng; Fumihiro Tanaka; Stefan B. Watzka; Laszlo Urban; Zsuzsanna Szalai; Hiroaki Akamatsu; Jin Hyoung Kang; Francisco J. Orlandi; Guzel Z. Mukhametshina; Andreas Pircher; Carlos Henrique Andrade Teixeira; Mike Aperghis; Gary J. Doherty; Ruth Doake; Tamer M. Fouad; David Harpole
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC

2025年肺癌基础与转化研究进展——聚焦NSCLC的概述与展望

Journal of Thoracic Oncology
IF20.8
2025-06-030
PRE
Celine Mascaux; Triparna Sen; Montse Sanchez-Cespedes; Sandra Ortiz-Cuaran; Yohan Bossé; Floris Dammeijer; Milena Cavic; Martin P. Barr; Surein Arulananda; Ricardo Armisen; Alice H. Berger; Fabrizio Bianchi; David P. Carbone; Ferdinando Cerciello; William W. Lockwood; Tetsuya Mitsudomi; Shuta Ohara; Katerina Politi; Sida Qin; Laila C. Roisman; Robert Samstein; Ferdinandos Skoulidis; Aaron C. Tan; Anish Thomas; Jianjun Zhang; Murry W. Wynes; Thomas John; Ming Sound Tsao
Neoadjuvant Concurrent Chemo–Immuno–Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)

新辅助同步化免放疗法联合手术及辅助免疫疗法治疗可切除Ⅲ期N2非小细胞肺癌：SQUAT试验（WJOG 12119L）的初步结果

Journal of Thoracic Oncology
IF20.8
2025-04-090
PRE
Akira Hamada; Junichi Soh; Akito Hata; Kiyoshi Nakamatsu; Mototsugu Shimokawa; Yasushi Yatabe; Jun Suzuki; Masahiro Tsuboi; Hidehito Horinouchi; Yuichi Sakairi; Masayuki Tanahashi; Shinichi Toyooka; Morihito Okada; Natusmi Matsuura; Hisayuki Shigematsu; Yasumasa Nishimura; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Tetsuya Mitsudomi
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-03-010
OA
Ohara, Shuta; Suda, Kenichi; Sudhaman, Sumedha; Hamada, Akira; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Kalashnikova, Ekaterina; Cheung, Samantha K.; Krainock, Michael; Feeney, Jordan; Sethi, Himanshu; Liu, Minetta C.; Soh, Junichi; Tsutani, Yasuhiro; Mitsudomi, Tetsuya
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies

辅助细胞毒性化疗和吉非替尼在切除肺癌中的纵向复发风险：一项III期研究的联合分析

LUNG CANCER
IF4.4
2025-03-010
OAAI
Akamatsu, Hiroaki; Nishikawa, Tomomi; Takeda, Yuriko; Misumi, Toshihiro; Aoki, Tadashi; Shoda, Hiroyasu; Yamashita, Motohiro; Sakakura, Noriaki; Daga, Haruko; Sugawara, Shunichi; Okishio, Kyoichi; Kenmotsu, Hirotsugu; Yamamoto, Nobuyuki; Tada, Hirohito; Tsuboi, Masahiro; Mitsudomi, Tetsuya
Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-07-011
OA
Yagishita, Shigehiro; Goto, Yasushi; Nishio, Makoto; Akamatsu, Hiroaki; Hayashi, Hidetoshi; Miura, Satoru; Tamada, Koji; Kagamu, Hiroshi; Hamada, Akinobu; Ohuchi, Mayu; Gemma, Akihiko; Yoshino, Ichiro; Misumi, Toshihiro; Hata, Akito; Hara, Satoshi; Kijima, Takashi; Masaki, Fujita; Iwasawa, Shunichiro; Nakagawa, Shintaro; Tatsuno, Masahiro; Mitsudomi, Tetsuya
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer

围手术期Durvalumab治疗可切除的非小细胞肺癌

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-11-02173
OA
Heymach, John V.; Harpole, David; Mitsudomi, Tetsuya; Taube, Janis M.; Galffy, Gabriella; Hochmair, Maximilian; Winder, Thomas; Zukov, Ruslan; Garbaos, Gabriel; Gao, Shugeng; Kuroda, Hiroaki; Ostoros, Gyula; Tran, Tho V.; You, Jian; Lee, Kang-Yun; Antonuzzo, Lorenzo; Papai-Szekely, Zsolt; Akamatsu, Hiroaki; Biswas, Bivas; Spira, Alexander; Crawford, Jeffrey; Le, Ha T.; Aperghis, Mike; Doherty, Gary J.; Mann, Helen; Fouad, Tamer M.; Reck, Martin

研究方向

暂未获取到该数据
Y
Yasushi Yatabe
H 指数:116论文数:1,236被引数:7.1万
K
Kenichi Suda
H 指数:40论文数:228被引数:5,821
T
Takashi Takahashi
H 指数:111论文数:1,195被引数:5.4万
K
Kazuto Nishio
H 指数:81论文数:1,116被引数:2.2万
J
Junichi Soh
H 指数:46论文数:424被引数:7,424
K
Kazuhiko Nakagawa
H 指数:103论文数:1,451被引数:6.1万
A
Akira Hamada
H 指数:14论文数:136被引数:934
K
Kazuko Sakai
H 指数:52论文数:614被引数:8,296
H
Hidetoshi Hayashi
H 指数:53论文数:645被引数:1.3万
S
Shuta Ohara
H 指数:13论文数:100被引数:947